跳转到内容

头孢达肟

维基百科,自由的百科全书
头孢达肟
临床资料
ATC码
  • 未分配
识别信息
  • (+)-(6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
CAS号80195-36-4  checkY
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard英语CompTox Chemicals Dashboard (EPA)
化学信息
化学式C14H15N5O6S2
摩尔质量413.434 g/mol
3D模型(JSmol英语JSmol
  • O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)C(=N\O)/c3nc(sc3)N)COC)C(=O)O
  • InChI=1S/C14H15N5O6S2/c1-25-2-5-3-26-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-27-14(15)16-6/h4,8,12,24H,2-3H2,1H3,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1
  • Key:HOGISBSFFHDTRM-GHXIOONMSA-N

头孢达肟(其国际非专利药品名称为“Cefdaloxime”)是一种第三代头孢菌素[1][2]

参考资料

[编辑]
  1. ^ Sader HS, Runyon BA, Erwin ME, Jones RN. Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis. Diagnostic Microbiology and Infectious Disease. February 1995, 21 (2): 105–10. PMID 7628189. doi:10.1016/0732-8893(94)00148-p. 
  2. ^ Jones, R N; Erwin, M E. Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin. Journal of Clinical Microbiology (American Society for Microbiology). 1992, 30 (5): 1297–1300. ISSN 0095-1137. doi:10.1128/jcm.30.5.1297-1300.1992.